David E. Rapp

David E. Rapp

Auto-generated profile, based on publicly available information

David E. Rapp

Department of Urology, University of Virginia, Charlottesville, Virginia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Journal of Urology
Verified
Journal Article
Closed access
DRDavid E. Rapp
David E. Rapp
KTKatherine W. Turk
Katherine W. Turk
GBGregory T. Bales
Gregory T. Bales
SCSean P. Cook
Sean P. Cook
Increasing evidence suggests that sensory nerve dysfunction may underlie several urological disorders, including interstitial cystitis and sensory urgency. We determined the effect of botulinum toxin type A (Allergan, Irvine, California) on baseline and chemically evoked release of the sensory neuropeptide, calcitonin gene-related peptide in an isolated bladder preparation. Whole rat bladders were incubated in a series of tissue baths containing physiological salt solution. Following bladder equilibration in PSS sequential incubation was performed and this sample was used to measure baseline CGRP release. To evoke CGRP release tissue was subsequently incubated in PSS containing capsaicin (30 nM) and adenosine triphosphate (10 microM). To measure the effect of BTX-A on baseline and evoked CGRP release bladders were incubated for 6 hours in an organ bath containing BTX-A (50 microM) or vehicle prior to bladder equilibration. CGRP release was determined by radioimmunoassay. Mean baseline release of CGRP +/- SEM was 346 +/- 44 pg/gm. Adenosine triphosphate/capsaicin application increased CGRP release by 75% over baseline (606 +/- 98 pg/gm, p < 0.005). BTX-A application resulted in a 19% decrease in baseline release of CGRP, although this difference did not achieve statistical significance. BTX-A application significantly decreased evoked CGRP by 62% vs control (606 +/- 98 vs 229 +/- 21 pg/gm, p < 0.005). BTX-A application inhibits the evoked release of CGRP from afferent nerve terminals in isolated rat bladder. This finding suggests a potential clinical benefit of BTX-A for the treatment of interstitial cystitis or sensory urgency.

1 August 2005 in European Urology
Verified
Journal Article
Closed access
DRDavid E. Rapp
David E. Rapp
MLMark B. Lyon
Mark B. Lyon
GBGregory T. Bales
Gregory T. Bales
SCSean P. Cook
Sean P. Cook

23 June 2006 in Medical Education
Verified
Journal Article
Closed access
PDF file
DRDavid E Rapp
David E Rapp

10 November 2004 in BJU International
Verified
Journal Article
Closed access
PDF file
DRDavid E. Rapp
David E. Rapp
ROR. Corey O'COnnor
R. Corey O'COnnor
EKErin E. Katz
Erin E. Katz
GSGary D. Steinberg
Gary D. Steinberg

1 April 2007 in International braz j urol
Verified
Journal Article
Open access
PDF file
DRDavid E. Rapp
David E. Rapp
WRWilliam Stuart Reynolds
William Stuart Reynolds
ALAlvaro Lucioni
Alvaro Lucioni
GBGregory T. Bales
Gregory T. Bales
OBJECTIVES: To describe and illustrate a new minimally invasive approach to the treatment of male stress urinary incontinence following prostatectomy. SURGICAL TECHNIQUE: Our initial experience consisted of four patients treated with the Advance sling for post-prostatectomy urinary incontinence. Sling placement involves the following steps: 1. Urethral dissection and mobilization, 2. Identification of surgical landmarks, 3. Placement of needle passers through the obturator foramen, 4. Mesh advancement, 5. Mesh tensioning and fixation, 6. Incision closure. COMMENTS: Based on our initial experience, we believe that the Advance Male Sling System may be a safe technique for the treatment of male stress urinary incontinence. This technique is easy to perform and may offer a reproducible, transobturator approach. Further patient accrual is ongoing to assess the safety and reproducibility of this technique. Also, additional study will focus on efficacy standards and complication rates.

4 March 2008 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
DRDavid E Rapp
David E Rapp
KKKathleen C Kobashi
Kathleen C Kobashi